List of bibliographic references
Number of relevant bibliographic references: 2.
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 2 | Adalimumab |
| 2 | Monoclonal antibody |
| 2 | Rheumatoid arthritis |
| 2 | Rheumatology |
| 1 | ACR, American College of Rheumatology |
| 1 | ANA, antinuclear antibody |
| 1 | Abbott laboratories |
| 1 | Adalimumab monotherapy |
| 1 | Adalimumab treatment groups |
| 1 | Adverse event |
| 1 | Adverse events |
| 1 | American college |
| 1 | Antirheumatic drugs |
| 1 | Arthritis |
| 1 | Arthritis rheum |
| 1 | Atkins |
| 1 | Baseline |
| 1 | Baseline value |
| 1 | CRP, C reactive protein |
| 1 | Chronic |
| 1 | Concomitant |
| 1 | Concomitant methotrexate |
| 1 | DAS, disease activity score |
| 1 | DMARDs, disease modifying antirheumatic drugs |
| 1 | Disability index |
| 1 | Disease activity |
| 1 | Disease activity score |
| 1 | Dmard |
| 1 | Dmards |
| 1 | Dos |
| 1 | Drug |
| 1 | ESR, erythrocyte sedimentation rate |
| 1 | EULAR, European League Against Rheumatism |
| 1 | Erythrocyte sedimentation rate |
| 1 | Eular |
| 1 | Eular response |
| 1 | Eular response rates |
| 1 | European league |
| 1 | Good eular response |
| 1 | HAQ DI, Disability Index of the Health Assessment Questionnaire |
| 1 | Health assessment questionnaire |
| 1 | Human |
| 1 | Injection site reaction |
| 1 | MTX, methotrexate |
| 1 | Methotrexate |
| 1 | Monoclonal |
| 1 | Monotherapy |
| 1 | NSAIDs, non-steroidal anti-inflammatory drugs |
| 1 | Other week |
| 1 | Patient assessment |
| 1 | Percentage change |
| 1 | Placebo |
| 1 | Previous dmard treatment |
| 1 | Primary efficacy |
| 1 | Putte |
| 1 | RA, rheumatoid arthritis |
| 1 | Randomised |
| 1 | Reactive protein |
| 1 | Regimen |
| 1 | Respective adalimumab doses |
| 1 | Response criteria |
| 1 | Response rates |
| 1 | Rheum |
| 1 | Rheumatoid |
| 1 | Riel |
| 1 | Riel plcm |
| 1 | Safety |
| 1 | Sample size |
| 1 | Serious infections |
| 1 | Significant difference |
| 1 | Significant differences |
| 1 | Study drug |
| 1 | TNF, tumour necrosis factor |
| 1 | Toxicity |
| 1 | Traditional dmards |
| 1 | Treatment |
| 1 | Treatment group |
| 1 | Treatment groups |
| 1 | Tumour necrosis factor |
| 1 | adalimumab |
| 1 | disease modifying antirheumatic drugs |
| 1 | human monoclonal antibodies |
| 1 | monotherapy |
| 1 | rheumatoid arthritis |
| 1 | tumour necrosis factor α |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "J. Sany"
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i \
-Sk "J. Sany" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Allemagne
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= J. Sany
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 |  |
